These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 16397234

  • 1. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
    Sunters A, Madureira PA, Pomeranz KM, Aubert M, Brosens JJ, Cook SJ, Burgering BM, Coombes RC, Lam EW.
    Cancer Res; 2006 Jan 01; 66(1):212-20. PubMed ID: 16397234
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells.
    Clavel S, Siffroi-Fernandez S, Coldefy AS, Boulukos K, Pisani DF, Dérijard B.
    Mol Cell Biol; 2010 Jan 01; 30(2):470-80. PubMed ID: 19917721
    [Abstract] [Full Text] [Related]

  • 3. The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells.
    Ho KK, Rosivatz E, Gunn RM, Smith ME, Stavropoulou AV, Rosivatz E, Numbere MG, Wong JB, Lafitte VG, Behrendt JM, Myatt SS, Hailes HC, Woscholski R, Lam EW.
    FEBS J; 2009 Aug 01; 276(15):4037-50. PubMed ID: 19549188
    [Abstract] [Full Text] [Related]

  • 4. Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
    Yang JY, Chang CJ, Xia W, Wang Y, Wong KK, Engelman JA, Du Y, Andreeff M, Hortobagyi GN, Hung MC.
    Cancer Res; 2010 Jun 01; 70(11):4709-18. PubMed ID: 20484037
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
    Okano J, Rustgi AK.
    J Biol Chem; 2001 Jun 01; 276(22):19555-64. PubMed ID: 11278851
    [Abstract] [Full Text] [Related]

  • 6. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
    Zhang L, Yang X, Li X, Li C, Zhao L, Zhou Y, Hou H.
    Int J Mol Med; 2015 Oct 01; 36(4):957-66. PubMed ID: 26310353
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W, Pew T, Zou M, Pang D, Conzen SD.
    J Biol Chem; 2005 Feb 11; 280(6):4117-24. PubMed ID: 15590693
    [Abstract] [Full Text] [Related]

  • 8. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.
    Fujiki K, Inamura H, Matsuoka M.
    Arch Toxicol; 2013 Dec 01; 87(12):2119-27. PubMed ID: 23673518
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA, Vellon L, Colomer R, Lupu R.
    Int J Cancer; 2005 May 20; 115(1):19-35. PubMed ID: 15657900
    [Abstract] [Full Text] [Related]

  • 11. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
    Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, Sunters A, Chan KY, Lam EW, Khoo US.
    PLoS One; 2010 Aug 20; 5(8):e12293. PubMed ID: 20808831
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
    Stadheim TA, Xiao H, Eastman A.
    Cancer Res; 2001 Feb 15; 61(4):1533-40. PubMed ID: 11245462
    [Abstract] [Full Text] [Related]

  • 13. FOXO3a: a novel player in thyroid carcinogenesis?
    Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Fuhrer D.
    Endocr Relat Cancer; 2009 Mar 15; 16(1):189-99. PubMed ID: 18845647
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
    Zhang T, Yang D, Fan Y, Xie P, Li H.
    Apoptosis; 2009 Oct 15; 14(10):1245-54. PubMed ID: 19669889
    [Abstract] [Full Text] [Related]

  • 15. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK, Mohebali N, Looi CY, Hasanpourghadi M, Pandurangan AK, Arya A, Karimian H, Mustafa MR.
    J Exp Clin Cancer Res; 2015 Dec 08; 34():147. PubMed ID: 26643256
    [Abstract] [Full Text] [Related]

  • 16. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C, Wang S, Dent P, Grant S.
    Mol Pharmacol; 2001 Jul 08; 60(1):143-54. PubMed ID: 11408609
    [Abstract] [Full Text] [Related]

  • 17. A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation.
    Wang X, Chen WR, Xing D.
    J Cell Physiol; 2012 Mar 08; 227(3):1168-78. PubMed ID: 21604264
    [Abstract] [Full Text] [Related]

  • 18. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
    Meng Z, Lv J, Luo Y, Lin Y, Zhu Y, Nie J, Yang T, Sun Y, Han X.
    Endocrinology; 2009 Dec 08; 150(12):5284-93. PubMed ID: 19837872
    [Abstract] [Full Text] [Related]

  • 19. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.
    McDaid HM, Horwitz SB.
    Mol Pharmacol; 2001 Aug 08; 60(2):290-301. PubMed ID: 11455016
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK).
    Lee LF, Li G, Templeton DJ, Ting JP.
    J Biol Chem; 1998 Oct 23; 273(43):28253-60. PubMed ID: 9774447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.